TY  - JOUR
AU  - Mendonça-de-Pontes, Roberia
AU  - Flores-Montero, Juan
AU  - Sanoja-Flores, Luzalba
AU  - Puig, Noemi
AU  - Pessoa-de-Magalhães, Roberto J
AU  - Corral-Mateos, Alba
AU  - Salgado, Anna Beatriz
AU  - Garcia-Sanchez, Omar
AU  - Perez-Moran, Jose
AU  - Mateos, Maria-Victoria
AU  - Burgos, Leire
AU  - Paiva, Bruno
AU  - Te-Marvelde, Jeroen
AU  - van-der-Velden, Vincent H J
AU  - Aguilar, Carlos
AU  - Barez, Abelardo
AU  - Garcia-Mateo, Aranzazu
AU  - Labrador, Jorge
AU  - Leoz, Pilar
AU  - Aguilera-Sanz, Carmen
AU  - Durie, Brian
AU  - van-Dongen, Jacques J M
AU  - Maiolino, Angelo
AU  - Sobral-da-Costa, Elaine
AU  - Orfao, Alberto
PY  - 2021
DO  - 10.3390/cancers13071704
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/17662
T2  - Cancers
AB  - B-cell regeneration during therapy has been considered as a strong prognostic factor in multiple myeloma (MM). However, the effects of therapy and hemodilution in bone marrow (BM) B-cell recovery have not been systematically evaluated during...
LA  - en
PB  - MDPI AG
KW  - B-cell regeneration
KW  - hemodilution
KW  - immunophenotyping
KW  - measurable residual disease
KW  - multiple myeloma
KW  - Adult
KW  - Bone Marrow
KW  - Follow-Up Studies
KW  - Hemodilution
KW  - Induction Chemotherapy
KW  - Multiple Myeloma
KW  - Plasma Cells
KW  - Prognosis
KW  - Stem Cell Transplantation
KW  - Cell Count
TI  - B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.
TY  - research article
VL  - 13
ER  -